Discover
ADXN
Addex Therapeutics Ltd
3.22
3 x 3.83
39 x 3.68
bid
ask
+
0.04
1.21%
21 @ 05:35 PM
3.02 -0.20 (6.17%)
| Ytd | -58.31% | |
| 1y | -63.92% |
3.09
day range
3.25
2.76
52 week range
10.95
| Open | 3.09 | Prev Close | 3.18 | Low | 3.09 | High | 3.25 | Mkt Cap | 5.64M |
| Vol | 4.51K | Avg Vol | 138.20K | EPS | -7.44 | P/E | N/A | Forward P/E | -159.83 |
| Beta | 1.87 | Short Ratio | 0.14 | Inst. Own | 0.17% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-01 | 50-d Avg | 4.19 | 200-d Avg | 6.21 | 1yr Est | 30.00 |
| Income Statement | |||
| Total Revenue | 9.95K | ||
| Revenues (USD) | 12.30K | ||
| Gross Profit | 9.95K | ||
| Operating Expenses | 655.30K | ||
| Research and Development Expense | 37.99K | ||
| Selling, General and Administrative Expense | 617.31K | ||
| Operating Income | -645.35K | ||
| Interest Expense | 1.18K | ||
| Net Income | -1.74M | ||
| Net Income Common Stock | -1.74M | ||
| Net Income Common Stock (USD) | -2.16M | ||
| Consolidated Income | -1.74M | ||
| Earnings per Basic Share | -0.01 | ||
| Earnings per Basic Share (USD) | -0.01 | ||
| Earnings per Diluted Share | -0.01 | ||
| Earning Before Interest & Taxes (EBIT) | -1.74M | ||
| Earning Before Interest & Taxes (USD) | -2.16M | ||
| Weighted Average Shares | 119.32M | ||
| Balance Sheet | |||
| Cash and Equivalents | 767.33K | ||
| Cash and Equivalents (USD) | 948.84K | ||
| Investments | 1.86M | ||
| Investments Current | 3.98K | ||
| Investments Non-Current | 1.86M | ||
| Trade and Non-Trade Receivables | 29.75K | ||
| Current Assets | 1.04M | ||
| Property, Plant & Equipment Net | 76.22K | ||
| Total Assets | 3.48M | ||
| Debt Current | 54.47K | ||
| Total Debt | 77.50K | ||
| Current Liabilities | 1.36M | ||
| Debt Non-Current | 23.02K | ||
| Total Liabilities | 1.57M | ||
| Accumulated Retained Earnings (Deficit) | -363.55M | ||
| Shareholders Equity | 1.91M | ||
| Shareholders Equity (USD) | 2.36M | ||
| Assets Non-Current | 2.44M | ||
| Total Debt (USD) | 95.83K | ||
| Liabilities Non-Current | 207.87K | ||
| Trade and Non-Trade Payables | 1.26M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 25.23K | ||
| Net Cash Flow from Financing | 289.71K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -178.55K | ||
| Issuance (Purchase) of Equity Shares | 322.40K | ||
| Issuance (Repayment) of Debt Securities | -32.65K | ||
| Net Cash Flow from Operations | -468.26K | ||
| Effect of Exchange Rate Changes on Cash | 10.73K | ||